Ex vivo experiments in human AAA tissues suggest that statins inhibit the Rac1/NF-κB pathway, with subsequent suppression of matrix metalloproteinase (MMP)-9 and cytokine secretion [29]. Here, MMP9 is linked to triple-A syndrome.